Skip to main content
OpenTrials
Completed

NCT Number: NCT02022410

CAS and Length of Hospital Stay After TKA

The purpose of the study is to prospectively evaluate patients who underwent total knee arthroplasty (TKA) using the Cumulated Ambulation Score (CAS)

Completed

Looking for future studies?

Notify Me

Key information

Conditions

CAS

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CHUV - Hopital Orthopedique

Lausanne, Canton of Vaud, 1011, Switzerland

About this study

The number of patients who receive a total knee arthroplasty (TKA) is steadily increasing and although the reliability and the results of this procedure are excellent, intensive functional rehabilitation is needed postoperatively to obtain satisfactory range of motion. Currently, the standard length of stay at our hospital is between 8 and 10 days for patients who undergo TKA.

The length of stay depends not only on factors such as early mobilization, pain management, major or minor complications and logistical or organizational problems (1) (2). It also depends on the availability of adequate services when the patient needs to be transferred to an appropriate facility. Each of these steps can be further developed in order to improve the quality of care for patients, reduce hospital costs and increase the availability of beds (3). As a result, the reduction in average length of stay would not only result in a reduction in cost but also a greater turnover in the number of patients. Several studies show that the application of a post-operative fast-track strategy may reduce the length of stay in a very significant manner with benefit for patients and hospitals (3).Thus, if their condition allows, patients would have rapid post-operative rehabilitation, with early joint mobilization at D0 (operative day) and walking from D1 (the first post-operative day).

The Cumulated Ambulation Score (CAS) (4) is a tool developed and tested for initial predicting the in-patient length of stay following a hip surgery. The CAS consists of documenting the patient's ability and independence while performing 3 basic daily activities (sit to stand, transfer out of bed and mobilization). It is calculated using a score of 0-2 for each parameter, giving a total daily score of 0 to 6 and a score of 0 to 18 during the first 3 post-operative days. The CAS is then the sum of scores of the first 3 post-operative days. This score proves to be an effective tool for predicting the length of stay, and other parameters investigated such as survival rate and return home after a proximal femoral surgery.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Adults after elective TKA -

Exclusion criteria

No consent form signed, neurological impairment

-

Treatment and study plan

CAS after primary and revision TKA

Other

CAS and RAPT

Primary outcomes

  1. CAS value

    Time frame: The 3rd day after TKA

    Record the CAS values for the first three operative days as mentioned in the protocol

Secondary outcomes

  1. Length of stay

    Time frame: between 4 days and 2 weeks

    Record number of in-hospital days

Other outcomes

  1. Destination at the end of the hospitalisation

    Time frame: at the moment of departure from in-hospital care

    Record the patients' destination at the end of the in-hospital stay: home, rehabilitation centre, residential home or other.

Sponsors and collaborators

Lead sponsor

University of Lausanne Hospitals

Other

Registry information

Official study title

Cumulated Ambulation Score and Length of Hospital Stay After TKA

Important dates

Study start
2013
Primary completion
2014
Study completion
2015
First posted
Dec 27, 2013
Registry last updated
Jun 2, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.